<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607931</url>
  </required_header>
  <id_info>
    <org_study_id>EFSD-2012</org_study_id>
    <nct_id>NCT01607931</nct_id>
    <nct_alias>NCT01540097</nct_alias>
  </id_info>
  <brief_title>Exercise, Glucose Kinetics, and the Incretin Effect</brief_title>
  <official_title>The Effects of Acute Exercise on Glucose Kinetics, Beta-cell Function and the Incretin Effect in Subjects Representative of the Whole Glucose Tolerance Continuum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human volunteers will be stratified by oral glucose tolerance status: normal glucose
      tolerant, impaired glucose tolerant, and type 2 diabetic. All subjects will undergo 4
      experimental trials: [1] an oral glucose tolerance test (OGTT) combined with infused and
      ingested stable isotopes of glucose to assess glucose kinetics. [2] a 1 hour bout of cycling
      exercise at 50% of maximum power output, immediately followed by the same OGTT combined with
      stable isotope glucose tracers used in trial 1. [3] an isoglycemic clamp to match the plasma
      glucose profile measured in trial 1. [4] a 1 hour bout of cycling exercise at 50% of maximum
      power output, immediately followed by an isoglycemic clamp to match the plasma glucose
      profile measured in trial 2.

      Exercise-induced changes in oral glucose tolerance, glucose kinetics, insulin and glucagon
      secretion, and the incretin effect will be examined. The exercise responses will be compared
      between the subjects groups of different glucose tolerance status.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose tolerance</measure>
    <time_frame>Plasma glucose will be measured at 10 minute intervals during the OGTT (3 hours) immediately following the period of rest or exercise</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incretin effect</measure>
    <time_frame>Plasma insulin and C-peptide will be measured at 10 minute intervals during the OGTT (3 hours) and isoglycemic clamp (3 hours) immediately following the period of rest or exercise</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Resting Trial</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>a 1 hour period of rest immediately prior to OGTT or isoglycemic clamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise Trial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a 1 hour cycling exercise bout immediately prior to the OGTT or isoglycemic clamp</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>1 hour of cycling at 50% of maximum power output</description>
    <arm_group_label>Exercise Trial</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-60 years

          -  BMI 18-35 kg/m2

        Exclusion Criteria:

          -  insulin dependency

          -  pregnancy

          -  presence or history of chronic cardiovascular, pulmonary, hepatic, renal, or
             hematological disease, or cancer

          -  contraindication to physical activity as assessed by ECG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2012</study_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Thomas Solomon</investigator_full_name>
    <investigator_title>Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Obesity</keyword>
  <keyword>Incretin effect</keyword>
  <keyword>GLP-1</keyword>
  <keyword>GIP</keyword>
  <keyword>Insulin secretion</keyword>
  <keyword>Glucagon</keyword>
  <keyword>Beta-cell function</keyword>
  <keyword>Disposition Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

